Market News
Breaking market news and updates

Moderna Shares Sink as Much as 25% After Melanoma Vaccine Data Surfaces Early, Ahead of ESMO Presentation
Moderna shares fell as much as 25% after partial Phase 3 melanoma vaccine data appeared online ahead of ESMO; confirmed results showed a 42% cut in recurrence or death risk with Merck's Keytruda.

Stock Market Today: Consumer Staples Leads While S&P 500 Slips
Consumer Staples led the session while the S&P 500 slips. See the validated market scorecard, sector performance, and what traders are watching next.

Spotify Shares Surge 10% on Subscriber Beat and Above-Consensus Q4 Operating Income Guidance
Spotify's Q3 2026 Premium subscriber beat and above-consensus Q4 operating income guidance, plus a higher gross margin target, sent shares up about 10%, even as revenue and EPS missed estimates.

Robinhood Rolls Out AI Trading Agents, Crypto Perpetual Futures, Cboe Earnings Contracts and Weekend Stock Trading Plans
Robinhood unveiled AI trading agents, Bitstamp-powered crypto perpetual futures, Cboe-listed binary earnings contracts and weekend equities trading plans at its 2026 HOOD Summit, with details on leverage tiers, disclosures and early share-price reaction.

Quest Diagnostics Discloses Unauthorized Access to Quanum Lab Services Manager, Says 'Certain Patient Records' Accessed
Quest Diagnostics said in a Thursday regulatory filing that it found unauthorized access to its Quanum Lab Services Manager and believes certain patient records were accessed, News4JAX reported. Scope remains under investigation.

Lockheed Martin Raises 2026 Guidance Again as Q3 Sales Rise 11% to $20.7 Billion, Backlog Hits Record $292 Billion
Lockheed Martin raised its 2026 sales and cash flow guidance after third-quarter revenue rose 11% to $20.7 billion and backlog hit a record $292 billion, led by PAC-3 and THAAD missile demand, per TradingView and Defence Industry Europe.

P&G Lifts FY2027 All-In Sales Outlook to 2%-4% on Thorne Deal After Q1 Beat; Cost Headwind Raised to $0.79 a Share
P&G raised its fiscal 2027 all-in sales growth outlook to 2%-4% from 1%-3% to reflect the Thorne acquisition after first-quarter net sales of $23.3 billion and core EPS of $2.00 beat consensus, while lifting its estimated after-tax cost headwind to $0.79 a share.

Nvidia and Tesla to Fund $2.8 Billion Expansion of Samsung Electro-Mechanics' AI Chip Substrate Lines, Maeil Reports
Maeil Business Newspaper reported on October 22 that Nvidia (2.6 trillion won) and Tesla (1.1 trillion won) will fund 3.7 trillion won ($2.8 billion) of FC-BGA substrate capacity at Samsung Electro-Mechanics' Sejong and Busan sites. The companies have not publicly confirmed the arrangement.

American Airlines Deepens 2026 Loss Forecast to $1-$1.60 a Share as Fuel Costs Squeeze Record Revenue
American Airlines widened its 2026 adjusted loss forecast to $1-$1.60 a share after fuel costs offset record third-quarter revenue, CNBC reported, with shares slipping in pre-market trading.

LSEG to Buy Credit-Data Specialist Octus From Permira for $3.535 Billion in Cash
LSEG has agreed to acquire credit intelligence and data provider Octus from Permira funds and management for $3.535 billion in cash, financed by external debt, with closing expected in H1 2027 subject to regulatory approval.

Tesla's Automotive Margin Rebounds to 18.1% as AI and Optimus Spending Pushes Costs Higher
Tesla's Q3 2026 results showed automotive gross margin excluding credits improving to 18.1% even as operating expenses rose 39% on AI and Optimus spending, with revenue flat at $28.05 billion.

Meta Narrows Full-Year Capex Range, Unveils Nonvoting Class C Shares Amid Litigation Costs
Meta narrowed full-year capex guidance to $135-$145 billion, disclosed a new nonvoting Class C share class to help fund AI growth, and guided Q4 revenue above analyst estimates, while absorbing legal costs from a child-safety settlement and a New Mexico privacy judgment, per CNBC.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
